ViewRay, Inc.
VRAY
VRAY was delisted on the 25th of July, 2023.
145 hedge funds and large institutions have $288M invested in ViewRay, Inc. in 2019 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 22 closing their positions.
80% more call options, than puts
Call options by funds: $7.18M | Put options by funds: $3.99M
36% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 22
31% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 42
5% more funds holding
Funds holding: 138 → 145 (+7)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
69% less capital invested
Capital invested by funds: $931M → $288M (-$644M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPU
Lansdowne Partners (UK)
London,
United Kingdom
|
+$14.2M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$13.3M |
| 3 |
BC
Broadfin Capital
New York
|
+$12.6M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$12.2M |
| 5 |
Barclays
London,
United Kingdom
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$45.4M |
| 2 |
GC
Greenvale Capital
London,
United Kingdom
|
-$24.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$17.8M |
| 4 |
Goldman Sachs
New York
|
-$14.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.8M |
VRAY Hedge Fund Activity: Q3 2019 in Review
145 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in ViewRay, Inc. (VRAY) for Q3 2019, worth a combined $288M — down 69% from $931M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new VRAY positions and 22 closed out — a net gain of 8 holders — while 55 added to existing stakes and 42 trimmed.
The largest buyer was Lansdowne Partners (UK), opening a new position worth an estimated $14.2M. The largest seller was OrbiMed, exiting entirely with an estimated $45.4M sold.
- 145 institutional investors held ViewRay, Inc. (VRAY) as of Q3 2019, up from 138 in Q2 2019.
- Funds reported $288M of ViewRay, Inc. stock for Q3 2019, down 69% quarter-over-quarter.
- 30 funds opened new ViewRay, Inc. positions in Q3 2019 and 22 closed out, a net change of +8 holders.
- The largest ViewRay, Inc. buyer in Q3 2019 was Lansdowne Partners (UK), an estimated $14.2M added.
- The largest ViewRay, Inc. seller in Q3 2019 was OrbiMed, an estimated $45.4M sold.
Based on aggregated 13F filings for Q3 2019.